塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/23 | 5,935 | 6,023 | 5,933 | 6,004 | +104 | +1.8% | 1,203,700 |
2021/03/22 | 5,909 | 5,944 | 5,874 | 5,900 | -89 | -1.5% | 1,085,200 |
2021/03/19 | 5,922 | 6,009 | 5,915 | 5,989 | +66 | +1.1% | 1,626,200 |
2021/03/18 | 5,888 | 5,943 | 5,865 | 5,923 | +44 | +0.7% | 1,072,200 |
2021/03/17 | 5,808 | 5,883 | 5,729 | 5,879 | -29 | -0.5% | 1,445,100 |
2021/03/16 | 5,988 | 5,995 | 5,844 | 5,908 | -180 | -3% | 1,620,700 |
2021/03/15 | 5,965 | 6,088 | 5,954 | 6,088 | +120 | +2% | 1,074,000 |
2021/03/12 | 6,000 | 6,000 | 5,855 | 5,968 | +18 | +0.3% | 1,824,300 |
2021/03/11 | 5,941 | 5,966 | 5,892 | 5,950 | +25 | +0.4% | 1,232,200 |
2021/03/10 | 5,798 | 5,939 | 5,775 | 5,925 | +186 | +3.2% | 1,508,600 |
2021/03/09 | 5,639 | 5,745 | 5,612 | 5,739 | +167 | +3% | 1,010,500 |
2021/03/08 | 5,505 | 5,615 | 5,500 | 5,572 | +112 | +2.1% | 853,800 |
2021/03/05 | 5,415 | 5,464 | 5,372 | 5,460 | +31 | +0.6% | 993,000 |
2021/03/04 | 5,547 | 5,547 | 5,386 | 5,429 | -157 | -2.8% | 1,558,700 |
2021/03/03 | 5,576 | 5,600 | 5,540 | 5,586 | +72 | +1.3% | 928,100 |
2021/03/02 | 5,500 | 5,543 | 5,463 | 5,514 | +18 | +0.3% | 822,500 |
2021/03/01 | 5,522 | 5,553 | 5,465 | 5,496 | +83 | +1.5% | 819,000 |
2021/02/26 | 5,700 | 5,700 | 5,404 | 5,413 | -309 | -5.4% | 2,307,000 |
2021/02/25 | 5,895 | 5,897 | 5,722 | 5,722 | -99 | -1.7% | 1,323,700 |
2021/02/24 | 5,896 | 5,921 | 5,815 | 5,821 | +10 | +0.2% | 1,851,800 |
2021/02/22 | 5,866 | 5,924 | 5,811 | 5,811 | -93 | -1.6% | 867,900 |
2021/02/19 | 5,950 | 5,960 | 5,885 | 5,904 | -80 | -1.3% | 742,000 |
2021/02/18 | 6,066 | 6,085 | 5,959 | 5,984 | -63 | -1% | 1,059,600 |
2021/02/17 | 6,133 | 6,136 | 6,021 | 6,047 | -91 | -1.5% | 907,700 |
2021/02/16 | 6,075 | 6,170 | 6,058 | 6,138 | +68 | +1.1% | 1,011,500 |
2021/02/15 | 6,011 | 6,070 | 5,989 | 6,070 | +94 | +1.6% | 837,800 |
2021/02/12 | 6,072 | 6,080 | 5,963 | 5,976 | +4 | +0.1% | 1,519,100 |
2021/02/10 | 5,934 | 5,996 | 5,873 | 5,972 | +131 | +2.2% | 1,082,000 |
2021/02/09 | 5,906 | 5,922 | 5,811 | 5,841 | -100 | -1.7% | 865,900 |
2021/02/08 | 5,940 | 5,962 | 5,880 | 5,941 | +83 | +1.4% | 1,047,900 |
2021/02/05 | 5,776 | 5,863 | 5,761 | 5,858 | +129 | +2.3% | 1,114,000 |
2021/02/04 | 5,755 | 5,786 | 5,685 | 5,729 | -23 | -0.4% | 781,900 |
2021/02/03 | 5,650 | 5,752 | 5,611 | 5,752 | +146 | +2.6% | 1,034,500 |
2021/02/02 | 5,744 | 5,745 | 5,551 | 5,606 | -109 | -1.9% | 1,186,400 |
2021/02/01 | 5,697 | 5,766 | 5,602 | 5,715 | +35 | +0.6% | 1,032,800 |
2021/01/29 | 5,700 | 5,757 | 5,638 | 5,680 | -51 | -0.9% | 932,100 |
2021/01/28 | 5,670 | 5,733 | 5,623 | 5,731 | -30 | -0.5% | 1,096,700 |
2021/01/27 | 5,735 | 5,771 | 5,702 | 5,761 | +64 | +1.1% | 823,400 |
2021/01/26 | 5,768 | 5,778 | 5,691 | 5,697 | -54 | -0.9% | 698,500 |
2021/01/25 | 5,690 | 5,760 | 5,677 | 5,751 | +93 | +1.6% | 658,000 |
2021/01/22 | 5,654 | 5,696 | 5,601 | 5,658 | -25 | -0.4% | 901,700 |
2021/01/21 | 5,710 | 5,748 | 5,653 | 5,683 | -49 | -0.9% | 951,700 |
2021/01/20 | 5,711 | 5,745 | 5,666 | 5,732 | +44 | +0.8% | 1,010,800 |
2021/01/19 | 5,772 | 5,780 | 5,665 | 5,688 | -81 | -1.4% | 842,900 |
2021/01/18 | 5,818 | 5,823 | 5,742 | 5,769 | -21 | -0.4% | 607,900 |
2021/01/15 | 5,812 | 5,876 | 5,772 | 5,790 | -51 | -0.9% | 881,300 |
2021/01/14 | 5,843 | 5,888 | 5,786 | 5,841 | -44 | -0.7% | 960,000 |
2021/01/13 | 5,945 | 5,945 | 5,833 | 5,885 | -70 | -1.2% | 1,027,600 |
2021/01/12 | 5,940 | 5,999 | 5,860 | 5,955 | +114 | +2% | 1,276,600 |
2021/01/08 | 5,791 | 5,841 | 5,771 | 5,841 | +105 | +1.8% | 1,290,000 |
901~
950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム